Leukemic stem cell. The presence of a cytokine-enriched microenvironment leads to a BCR-ABL1–independent activation of STAT3 and STAT5 via JAK2. Targeting both pathways via BCR-ABL1 and JAK2 TKIs would interfere with these essential survival signals.